Industry News
Botstein awarded Gruber prize
Dr David Botstein, of the Lewis-Sigler Institute for Integrative Genomics at Princeton University, was yesterday awarded the prestigious 2003 Peter Gruber Genetics prize. [ + ]
Research exposes fire ant's Achilles heel
Across large areas of the southern United States, the most social primate on Planet Earth has come into painful conflict with one of the world's most unlovable social insects - the South American fire ant, Solenopsis victor. [ + ]
Benefits outweigh gene therapy risks
The risks of developing cancer as a side-effect of gene therapy were outweighed by the potential benefit to the patients, one of the scientists involved in gene therapy clinical trials said yesterday at the XIX International Congress of Genetics. [ + ]
Gruber winner Botstein calls for better gene name system
Genomics expert Prof David Botstein says it's a fact that biologists would rather share a toothbrush than a gene's name -- the yeast gene that he knows as ABC1 is apparently known to fruit fly geneticists as 'bride of frizzled disco'. [ + ]
AAV shows promise as mutation repair vector
Adeno-associated virus (AAV) shows promise as a gene-targeting vector for repair of mutations, particularly in cell populations that can be treated ex vivo and reinfused back into the host, according to David Russell, a professor at the University of Washington. [ + ]
Panbio scores FDA approval, world first
Bribane diagnostic biotech Panbio has become the first company ever to rate US FDA approval for a West Nile virus (WNV) immunoassay diagnostic kit. [ + ]
BioFirst lures researchers
NSW’s BioFirst awards have attracted two top overseas researchers to the state, in the first of this year’s appointments for overseas experts. [ + ]
EQiTX granted US patent
WA biotech EQiTX has been granted a US patent on its Gingerol pain and inflammation compound. [ + ]
Amgen submits psoriasis drug for marketing review
Amgen, the world's No. 1 biotechnology company, said it has asked US regulators to approve the sale of its rheumatoid arthritis drug, Enbrel, to treat the skin disorder psoriasis. [ + ]
Mayne forced to re-recall
Complementary medicine giant Mayne Health has been caught out in the warehouse department, with some 650 bottles of TGA-banned and recalled products being accidentally delivered to retailers across Australia. [ + ]
Melbourne scientist overturns 30 year calcium dogma
A University of Melbourne research team has overturned 30 years of dogma on how a cell transports calcium, revealing potential insights into cancer and neuro-degenerative diseases.
[ + ]Germline therapy tipped for longer life
Evolution doesn't care what happens to the body after reproduction, says Prof Miroslav Radman, so we humans should consider taking out little extra cellular life insurance to ward off cancer in our twilight years. [ + ]
CSIRO scans cattle data for parasite info
CSIRO Livestock Industries is leafing through vast amounts of historical cattle data to identify if genetics have had any impact on parasite infestation levels over the years. [ + ]
IBM keeps to the bioIT straight and narrow
IBM said it has no plans to take its bioIT products direct to the consumer, despite the potential for increased sales numbers. [ + ]
Mouse model could ID mental illness gene
A schizophrenic mouse model has led the way to identification of a gene potentially predisposing humans to the devastating human mental illness. [ + ]

